Related references
Note: Only part of the references are listed.Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning
Akos Nemeth et al.
FRONTIERS IN GENETICS (2022)
10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes
Manon Belhassen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Non-Alcoholic Fatty Liver in Patients with Chylomicronemia
Melanie Maltais et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Prevalence of familial chylomicronemia syndrome in a quaternary care center
Vincent A. Pallazola et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
A Comprehensive Update on the Chylomicronemia Syndrome
Ronald B. Goldberg et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
The Chylomicronemia Syndrome Is Most Often Multifactorial A Narrative Review of Causes and Treatment
Alan Chait et al.
ANNALS OF INTERNAL MEDICINE (2019)
Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia
Martine Paquette et al.
ATHEROSCLEROSIS (2019)
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an FCS score
Philippe Moulin et al.
ATHEROSCLEROSIS (2018)
The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital
Nivedita Patni et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
Robert A. Hegele et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary
Gyorgy Paragh et al.
ATHEROSCLEROSIS (2018)
Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia
A. P. Beigneux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Expanding the molecular diversity and phenotypic spectrum of glycerol 3-phosphate dehydrogenase 1 deficiency
Carlo Dionisi-Vici et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Geesje M. Dallinga-Thie et al.
CURRENT CARDIOLOGY REPORTS (2016)
Chylomicronaemia-current diagnosis and future therapies
Amanda J. Brahm et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Details acquired from medical history and patients' experience of empathy - two sides of the same coin
Friedemann Ohm et al.
BMC MEDICAL EDUCATION (2013)
Greedy function approximation: A gradient boosting machine
JH Friedman
ANNALS OF STATISTICS (2001)